Results 161 to 170 of about 27,706 (210)

Efficacy and tolerability of artemether–lumefantrine and pyronaridine-artesunate for uncomplicated Plasmodium falciparum malaria in Niger

open access: yes
Alhousseini D   +11 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Artemether-Lumefantrine: An Option for Malaria

Annals of Pharmacotherapy, 2012
Objective: To review the pharmacology, pharmacokinetics, safety, and efficacy of artemether-lumefantrine for the treatment of Plasmodium falciparum malaria. Data Sources: English-language articles indexed in PubMed (1947-November 2011)
Travis King
exaly   +3 more sources

Potential sonodynamic anticancer activities of artemether and liposome-encapsulated artemether

Chemical Communications, 2015
The potential application of artemether as a novel sonosensitizer for sonodynamic therapy was explored and illustrated for the first time.
Hai-Jun, Chen   +4 more
openaire   +2 more sources

Fatal Neurotoxicity of Arteether and Artemether

The American Journal of Tropical Medicine and Hygiene, 1994
Artemisinin (qinghaosu) and several derivatives have been developed and are in use as antimalarial drugs but scant information is available regarding animal or human toxicity. Following a eight-day, multiple-dose, pharmacokinetic study of arteether (AE) (10 mg/kg/day [n = 6] and 20 mg/kg/day [n = 6]) in dogs, all high-dose animals displayed a ...
T G, Brewer   +7 more
openaire   +2 more sources

The potential of artemether for the control of schistosomiasis

International Journal for Parasitology, 2001
Schistosomiasis continues to rank--following malaria--at the second position of the world's parasitic diseases in terms of the extent of endemic areas and the number of infected people. There is yet no vaccine available and the current mainstay of control is chemotherapy with praziquantel used as the drug of choice.
Utzinger J   +4 more
openaire   +3 more sources

Artemether

Reactions Weekly, 2017
openaire   +2 more sources

Home - About - Disclaimer - Privacy